Interleukin-2 and Pembrolizumab for Metastatic Kidney Cancer
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Adaptimmune
Centre Paul Strauss
Pfizer
Hospices Civils de Lyon
Duke University
Kazia Therapeutics Limited
Incyte Corporation
Incyte Corporation
Incyte Corporation
Trishula Therapeutics, Inc.
University of Washington
Case Comprehensive Cancer Center
Astellas Pharma Inc
University of Washington
University Hospital, Ghent
Cedars-Sinai Medical Center
PureTech
University of Washington
Daiichi Sankyo
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Astellas Pharma Inc
Acepodia Biotech, Inc.
Astellas Pharma Inc
University of Utah
M.D. Anderson Cancer Center
Cedars-Sinai Medical Center
Duke University
Kyowa Kirin Co., Ltd.
Eli Lilly and Company
University of California, San Francisco
Case Comprehensive Cancer Center
Ikena Oncology
NextCure, Inc.
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Icahn School of Medicine at Mount Sinai
Tavanta Therapeutics
Processa Pharmaceuticals
Rutgers, The State University of New Jersey
University of Chicago
Bayer
Columbia University
Eastern Cooperative Oncology Group
Endocyte
University of California, San Francisco
M.D. Anderson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
Nektar Therapeutics
Herlev Hospital
Quadriga Biosciences, Inc.